Home Innovation That Matters

Innovation That Matters

Inside Perspectives on Cancer Immunotherapy: An Interview with Juno CEO Hans Bishop

Juno Therapeutics President and CEO Hans Bishop leads one of the most dynamic, pioneering companies in the field of cancer immunotherapy. He describes this exciting, new strategy for destroying cancer cells as transformational, and he predicts it eventually will become the standard of care,...

Forging the Unknown Frontiers of Chemistry and Science

Julian Adams – widely regarded as one of the most innovative and dedicated leaders in the biotechnology industry – will be the first to admit that behind every success, there has been a failure. But, after nearly three decades in the industry, the synthetic...

FDA Approves Lenvima for Treatment of Progressive Radioiodine-refractory Differentiated Thyroid Cancer (RR-DTC)

FDA announced this February the approval of lenvima (lenvatinib), a novel investigative chemotherapy for patients with progressive radioiodine-refractory differentiated thyroid cancer (RR-DTC).  Lenvima is developed by Eisai Co., Ltd headquartered in Tokyo, Japan.  This approval is one day after the publication of Eisai’s phase...

British Biotech Industry Aims to Keep Regulatory Alignment with EU Since Brexit Vote, but Also Eyes China Market

The challenges faced by drug developers can be unique in different countries, which may have various regulatory and approvals processes, reimbursement policies and access to investment capital. Working alongside these companies are national biotech and pharmaceutical trade groups which work as partners to help...

Combatting the Hep B Virus: An Interview with George Hartman, Novira Therapeutics

Dr. George Hartman is the Vice-President of Chemistry and Preclinical Development and cofounder of Novira Therapeutics, a clinical stage, privately-held company that discovers and develops small molecule antiviral drugs for the treatment of chronic hepatitis B (CHB) infection.  Novira’s lead core inhibitor candidate, NVR...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

A Futuristic Biopharma Company Addressing Some of the World’s Biggest Health...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) For the past few years, PureTech Health has been building a new R&D model for advancing breakthrough...